Searched for
ORBIMED ASIA
Nutrition brand TruNativ closes $30 million round with OrbiMed Advisors LLCClean-label nutrition brand TruNativ has secured $30 million from OrbiMed Advisors LLC to boost distribution, expand its product range, and...- Laxmi Dental raises Rs 314 crore from anchor investors ahead of IPOOrbiMed-backed Laxmi Dental raised over Rs 314 crore from anchor investors before its IPO for public subscription. The anchor round include...
- Laxmi Dental IPO to open next week with price band of Rs 407-428 per shareOrbiMed-backed Laxmi Dental on Wednesday said it has fixed the price band at Rs 407-428 per share for Rs 698 crore initial public offer whi...
- Dental products firm Laxmi Dental gets Sebi's go ahead to float IPOLaxmi Dental Ltd has received approval from Sebi for its IPO, comprising a fresh issue of ₹150 crore and an OFS of 1.28 crore shares. Proce...
- Suraksha Diagnostic gets Sebi's go ahead to float IPOIntegrated diagnostic chain Suraksha Diagnostic Ltd has received Sebi's go ahead to raise funds through an initial public offering (IPO), a...
- Laxmi Dental files draft papers to raise funds via IPODental products company Laxmi Dental Ltd has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial...
- General Atlantic, other PE funds in talks for majority stake in AIMSGeneral Atlantic and KKR are among several private equity firms vying for a majority stake in Faridabad-based Asian Institute of Medical Sc...
- OrbiMed-backed Suraksha Diagnostic files IPO papersOrbiMed-backed Suraksha Diagnostic has filed the draft red herring prospectus (DRHP) with capital markets regulator SEBI to float an initia...
- Kolkata-based Suraksha Diagnostic files IPO draft papers with SebiSuraksha Diagnostic Limited has filed the draft red herring prospectus (DRHP) with capital markets regulator Securities and Exchange Board ...
- Arcatron Mobility raise growth capital from OrbiMed, a global healthcare-focused investment firmArcatron Mobility has raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to increase R...
- Sebi gives nod for four IPOsHealthcare products distributors Entero Healthcare's IPO consists of a fresh issue of ₹1,000 crore and an offer for sale of 85.57 lakh shar...
- Entero gets Sebi nod for IPOThe Company’s initial public offering comprises a fresh issue of up to Rs 1000 crore and an offer for sale of up to 8,557,597 equity shares.
- Entero Healthcare files draft IPO papers with Sebi with fresh issue worth Rs 1000 crThe offer is being made through the book building process, where 75% of the issue is reserved for qualified institutional buyers, 10% for n...
- Innvolution secures growth capital from OrbiMed to advance R&D, expand product line and enter global marketsInnvolution has recently received substantial growth capital from OrbiMed, an investment firm dedicated to healthcare
- Marksans Pharma hits upper circuit as company considers preferential allotmentShares of Marksans Pharma rallied 20 per cent, its upper circuit limit, to Rs 83.70 on Friday. However the counter was trading at Rs 81.75 ...
- Vivimed Labs gets additional $7.5 million funding from OrbiMed AsiaThe company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing.
- Netmeds raises $14 million from Tanncam, Sistema Asia FundTanncam and Sistema will join early investors investment bank MAPE and OrbiMed Asia, along with Pradeep Dadha and his family, as stakeholde...
- Beams Hospitals in talks with PE investors to raise $20 millionThere is a sharp increase in the flow of risk capital to the healthcare sector in the past year driven by growing demand for quality servic...
- Shasun Pharma to invest Rs 250 crore in expansion next fiscalThe company has received approval to raise Rs 50 crore through preferential allotment of shares to Caduceus Asia Mauritius
- Shasun Pharmaceuticals to sell 11.93 stake to US firm OrbiMed for Rs 50 croreShasun Pharmaceuticals said its board has approved to sell 11.93 per cent stake to US- based healthcare investment firm OrbiMed for Rs 50 c...
Load More
